Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 18.


Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ross, Paul J, Silcocks, Paul, Greenhalf, William, Faluyi, Olusola Olusesan, Ma, Yuk Ting, Wadsley, Jonathan, Rawcliffe, Charlotte Louise, Valle, Juan W and Neoptolemos, John P
(2018) ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma. .


Primrose, John N, Fox, Richard P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg
et al (show 19 more authors) (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. LANCET ONCOLOGY, 20 (5). pp. 663-673.


Backen, Alison C, Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G, Madhusudan, Srinivasan, Maraveyas, Anthony
et al (show 9 more authors) (2018) Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. British Journal of Cancer, 119 (1). pp. 27-35.


Jones, Christopher M, Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek
et al (show 8 more authors) (2020) Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. BRITISH JOURNAL OF CANCER, 123 (5). pp. 709-713.


Exarchou, Klaire, Hu, Haiyi, Stephens, Nathan A, Moore, Andrew R, Kelly, Mark, Lamarca, Angela, Mansoor, Wasat, Hubner, Richard, McNamara, Mairead G, Smart, Howard
et al (show 3 more authors) (2022) Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter. ENDOCRINE, 78 (1). pp. 186-196.


Ghaneh, Paula, Palmer, Daniel, Cicconi, Silvia, Jackson, Richard, Halloran, Christopher Michael ORCID: 0000-0002-5471-4178, Rawcliffe, Charlotte, Sripadam, Rajaram, Mukherjee, Somnath, Soonawalla, Zahir, Wadsley, Jonathan
et al (show 26 more authors) (2022) Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. The lancet. Gastroenterology & hepatology, 8 (2). S2468-1253(22)00348-X-S2468-1253(22)00348-X.


Edeline, Julien, Lamarca, Angela, McNamara, Mairead G, Jacobs, Timothy, Hubner, Richard A, Palmer, Dan ORCID: 0000-0002-7147-5703, Koerkamp, Bas Groot, Johnson, Philip ORCID: 0000-0003-1404-0209, Guiu, Boris and Valle, Juan W
(2021) Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. CANCER TREATMENT REVIEWS, 99. 102258-.


McNamara, Mairead Geraldine, Goyal, Lipika, Doherty, Mark, Springfeld, Christoph, Cosgrove, David, Sjoquist, Katrin Marie, Park, Joon Oh, Verdaguer, Helena, Braconi, Chiara, Ross, Paul J
et al (show 5 more authors) (2020) NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121). FUTURE ONCOLOGY, 16 (16). pp. 1069-1081.


Ruszniewski, Philippe, Valle, Juan W, Lombard-Bohas, Catherine, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Perros, Petros, Holubec, Lubos, Delle Fave, Gianfranco, Smith, Denis, Niccoli, Patricia, Maisonobe, Pascal
et al (show 2 more authors) (2016) Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study. DIGESTIVE AND LIVER DISEASE, 48 (5). pp. 552-558.


Jones, Robert P ORCID: 0000-0001-5608-001X, Psarelli, Eftychia-Eirini ORCID: 0000-0002-3102-0288, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O'Reilly, Derek A
et al (show 92 more authors) (2019) Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154 (11). pp. 1038-1048.


Gray, Simon ORCID: 0000-0001-8396-3328, Lamarca, Angela, McNamara, Mairéad G, Edeline, Julien, Piper‐Hanley, Karen, Valle, Juan W and Hubner, Richard A
(2023) Prognostic and predictive factors for locoregional and systemic therapies in hepatocellular carcinoma. Liver Cancer International, 4 (1). pp. 13-27.


Lamarca, Angela, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Westwood, Thomas, Papaxoinis, Georgios, Nonaka, Daisuke, Vinjamuri, Sobhan, Valle, Juan W, Manoharan, Prakash and Mansoor, Wasat
(2018) <SUP>68</SUP>Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' Management. NEUROENDOCRINOLOGY, 106 (2). pp. 128-138.


Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari
et al (show 11 more authors) (2021) Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. LANCET ONCOLOGY, 22 (5). pp. 690-701.


Palmer, Daniel H ORCID: 0000-0002-7147-5703, Valle, Juan W, Ting Ma, Yuk, Faluyi, Olusola, Neoptolemos, John P, Jensen Gjertsen, Trine, Iversen, Berit, Amund Eriksen, Jon, Moller, Anne-Sophie, Aksnes, Anne-Kirsti
et al (show 2 more authors) (2020) TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial. BRITISH JOURNAL OF CANCER, 122 (7). pp. 971-977.


Gray, Simon ORCID: 0000-0001-8396-3328, Lamarca, Angela, Edeline, Julien, Klumpen, Heinz-Josef, Hubner, Richard A, McNamara, Mairead G and Valle, Juan W
(2022) Targeted Therapies for Perihilar Cholangiocarcinoma. CANCERS, 14 (7). 1789-.


Gray, Simon ORCID: 0000-0001-8396-3328, Letissier, Octave, d'Abrigeon, Constance, Shah, Dinakshi, Wardell, Stephen, Faluyi, Olusola, Lamarca, Angela, Hubner, Richard A, Edeline, Julien, Valle, Juan W
et al (show 1 more authors) (2023) Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes. CANCERS, 15 (11). 3047-.


Middleton, Gary, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony ORCID: 0000-0001-8547-1730, Shaw, Victoria E ORCID: 0000-0002-0429-0186, Wadsley, Jonathan, Valle, Juan W
et al (show 14 more authors) (2017) Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18 (4). pp. 486-499.


Aughton, Karen ORCID: 0000-0002-5184-5789, Elander, Nils O, Evans, Anthony ORCID: 0000-0001-8547-1730, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Mackey, John R, Scarfe, Andrew G, Valle, Juan W
et al (show 16 more authors) (2021) hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13 (22). 5758-.

This list was generated on Fri Feb 9 14:00:02 2024 GMT.